Skip to main content
Erschienen in: Arthritis Research & Therapy 5/2004

01.09.2004 | Review

Regulating the immune system: the induction of regulatory T cells in the periphery

verfasst von: Jane H Buckner, Steven F Ziegler

Erschienen in: Arthritis Research & Therapy | Ausgabe 5/2004

Einloggen, um Zugang zu erhalten

Abstract

The immune system has evolved a variety of mechanisms to achieve and maintain tolerance both centrally and in the periphery. Central tolerance is achieved through negative selection of autoreactive T cells, while peripheral tolerance is achieved primarily via three mechanisms: activation-induced cell death, anergy, and the induction of regulatory T cells. Three forms of these regulatory T cells have been described: those that function via the production of the cytokine IL-10 (T regulatory 1 cells), transforming growth factor beta (Th3 cells), and a population of T cells that suppresses proliferation via a cell-contact-dependent mechanism (CD4+CD25+ TR cells). The present review focuses on the third form of peripheral tolerance – the induction of regulatory T cells. The review will address the induction of the three types of regulatory T cells, the mechanisms by which they suppress T-cell responses in the periphery, the role they play in immune homeostasis, and the potential these cells have as therapeutic agents in immune-mediated disease.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sprent J, Kishimoto H: The thymus and negative selection. Immunol Rev. 2002, 185: 126-135. 10.1034/j.1600-065X.2002.18512.x.CrossRefPubMed Sprent J, Kishimoto H: The thymus and negative selection. Immunol Rev. 2002, 185: 126-135. 10.1034/j.1600-065X.2002.18512.x.CrossRefPubMed
2.
Zurück zum Zitat Schwartz RH: T cell anergy. Annu Rev Immunol. 2003, 21: 305-334. 10.1146/annurev.immunol.21.120601.141110.CrossRefPubMed Schwartz RH: T cell anergy. Annu Rev Immunol. 2003, 21: 305-334. 10.1146/annurev.immunol.21.120601.141110.CrossRefPubMed
3.
Zurück zum Zitat Groux H: An overview of regulatory T cells. Microbes Infect. 2001, 3: 883-889. 10.1016/S1286-4579(01)01448-4.CrossRefPubMed Groux H: An overview of regulatory T cells. Microbes Infect. 2001, 3: 883-889. 10.1016/S1286-4579(01)01448-4.CrossRefPubMed
4.
Zurück zum Zitat Cottrez F, Groux H: Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells. Transplantation. 2004, 77: S12-S15. 10.1097/01.TP.0000106471.23410.32.CrossRefPubMed Cottrez F, Groux H: Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells. Transplantation. 2004, 77: S12-S15. 10.1097/01.TP.0000106471.23410.32.CrossRefPubMed
5.
Zurück zum Zitat Bluestone JA, Abbas AK: Natural versus adaptive regulatory T cells. Nat Rev Immunol. 2003, 3: 253-257. 10.1038/nri1032.CrossRefPubMed Bluestone JA, Abbas AK: Natural versus adaptive regulatory T cells. Nat Rev Immunol. 2003, 3: 253-257. 10.1038/nri1032.CrossRefPubMed
6.
Zurück zum Zitat Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003, 4: 330-336. 10.1038/ni904.CrossRefPubMed Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003, 4: 330-336. 10.1038/ni904.CrossRefPubMed
7.
Zurück zum Zitat Khattri R, Cox T, Yasayko SA, Ramsdell F: An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 2003, 4: 337-342. 10.1038/ni909.CrossRefPubMed Khattri R, Cox T, Yasayko SA, Ramsdell F: An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 2003, 4: 337-342. 10.1038/ni909.CrossRefPubMed
8.
Zurück zum Zitat Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003, 299: 1057-1061. 10.1126/science.1079490.CrossRefPubMed Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003, 299: 1057-1061. 10.1126/science.1079490.CrossRefPubMed
9.
Zurück zum Zitat Ramsdell F: Foxp3 and natural regulatory T cells: key to a cell lineage?. Immunity. 2003, 19: 165-168. 10.1016/S1074-7613(03)00207-3.CrossRefPubMed Ramsdell F: Foxp3 and natural regulatory T cells: key to a cell lineage?. Immunity. 2003, 19: 165-168. 10.1016/S1074-7613(03)00207-3.CrossRefPubMed
10.
Zurück zum Zitat Shevach EM: CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol. 2002, 2: 389-400.PubMed Shevach EM: CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol. 2002, 2: 389-400.PubMed
11.
Zurück zum Zitat Sakaguchi S: Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 2000, 101: 455-458. 10.1016/S0092-8674(00)80856-9.CrossRefPubMed Sakaguchi S: Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 2000, 101: 455-458. 10.1016/S0092-8674(00)80856-9.CrossRefPubMed
12.
Zurück zum Zitat Weiner HL: Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect. 2001, 3: 947-954. 10.1016/S1286-4579(01)01456-3.CrossRefPubMed Weiner HL: Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect. 2001, 3: 947-954. 10.1016/S1286-4579(01)01456-3.CrossRefPubMed
13.
Zurück zum Zitat Levings MK, Bacchetta R, Schulz U, Roncarolo MG: The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol. 2002, 129: 263-276. 10.1159/000067596.CrossRefPubMed Levings MK, Bacchetta R, Schulz U, Roncarolo MG: The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol. 2002, 129: 263-276. 10.1159/000067596.CrossRefPubMed
14.
Zurück zum Zitat Whitacre CC, Gienapp IE, Orosz CG, Bitar DM: Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol. 1991, 147: 2155-2163.PubMed Whitacre CC, Gienapp IE, Orosz CG, Bitar DM: Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol. 1991, 147: 2155-2163.PubMed
15.
Zurück zum Zitat Melamed D, Friedman A: Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol. 1993, 23: 935-942.CrossRefPubMed Melamed D, Friedman A: Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol. 1993, 23: 935-942.CrossRefPubMed
16.
Zurück zum Zitat Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL: Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci USA. 1992, 89: 421-425.PubMedCentralCrossRefPubMed Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL: Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci USA. 1992, 89: 421-425.PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Lucas PJ, Kim SJ, Melby SJ, Gress RE: Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor. J Exp Med. 2000, 191: 1187-1196. 10.1084/jem.191.7.1187.PubMedCentralCrossRefPubMed Lucas PJ, Kim SJ, Melby SJ, Gress RE: Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor. J Exp Med. 2000, 191: 1187-1196. 10.1084/jem.191.7.1187.PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Letterio JJ, Roberts AB: Regulation of immune responses by TGF-beta. Annu Rev Immunol. 1998, 16: 137-161. 10.1146/annurev.immunol.16.1.137.CrossRefPubMed Letterio JJ, Roberts AB: Regulation of immune responses by TGF-beta. Annu Rev Immunol. 1998, 16: 137-161. 10.1146/annurev.immunol.16.1.137.CrossRefPubMed
19.
Zurück zum Zitat Moore KW, de Waal MR, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001, 19: 683-765. 10.1146/annurev.immunol.19.1.683.CrossRefPubMed Moore KW, de Waal MR, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001, 19: 683-765. 10.1146/annurev.immunol.19.1.683.CrossRefPubMed
20.
Zurück zum Zitat Steinbrink K, Graulich E, Kubsch S, Knop J, Enk AH: CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood. 2002, 99: 2468-2476. 10.1182/blood.V99.7.2468.CrossRefPubMed Steinbrink K, Graulich E, Kubsch S, Knop J, Enk AH: CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood. 2002, 99: 2468-2476. 10.1182/blood.V99.7.2468.CrossRefPubMed
21.
Zurück zum Zitat Koppelman B, Neefjes JJ, de Vries JE, de Waal MR: Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity. 1997, 7: 861-871. 10.1016/S1074-7613(00)80404-5.CrossRefPubMed Koppelman B, Neefjes JJ, de Vries JE, de Waal MR: Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity. 1997, 7: 861-871. 10.1016/S1074-7613(00)80404-5.CrossRefPubMed
22.
Zurück zum Zitat Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997, 389: 737-742. 10.1038/39614.CrossRefPubMed Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997, 389: 737-742. 10.1038/39614.CrossRefPubMed
23.
Zurück zum Zitat Groux H, Bigler M, de Vries JE, Roncarolo MG: Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+T cells. J Exp Med. 1996, 184: 19-29. 10.1084/jem.184.1.19.CrossRefPubMed Groux H, Bigler M, de Vries JE, Roncarolo MG: Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+T cells. J Exp Med. 1996, 184: 19-29. 10.1084/jem.184.1.19.CrossRefPubMed
24.
Zurück zum Zitat Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH: Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med. 2000, 192: 1213-1222. 10.1084/jem.192.9.1213.PubMedCentralCrossRefPubMed Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH: Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med. 2000, 192: 1213-1222. 10.1084/jem.192.9.1213.PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat Lecart S, Boulay V, Raison-Peyron N, Bousquet J, Meunier L, Yssel H, Pene J: Phenotypic characterization of human CD4+regulatory T cells obtained from cutaneous dinitrochlorobenzene-induced delayed type hypersensitivity reactions. J Invest Dermatol. 2001, 117: 318-325. 10.1046/j.1523-1747.2001.01403.x.CrossRefPubMed Lecart S, Boulay V, Raison-Peyron N, Bousquet J, Meunier L, Yssel H, Pene J: Phenotypic characterization of human CD4+regulatory T cells obtained from cutaneous dinitrochlorobenzene-induced delayed type hypersensitivity reactions. J Invest Dermatol. 2001, 117: 318-325. 10.1046/j.1523-1747.2001.01403.x.CrossRefPubMed
26.
Zurück zum Zitat Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G: Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol. 2000, 114: 295-302. 10.1046/j.1523-1747.2000.00881.x.CrossRefPubMed Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G: Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol. 2000, 114: 295-302. 10.1046/j.1523-1747.2000.00881.x.CrossRefPubMed
27.
Zurück zum Zitat Kitani A, Chua K, Nakamura K, Strober W: Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells. J Immunol. 2000, 165: 691-702.CrossRefPubMed Kitani A, Chua K, Nakamura K, Strober W: Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells. J Immunol. 2000, 165: 691-702.CrossRefPubMed
28.
Zurück zum Zitat Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP: Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature. 2003, 421: 388-392. 10.1038/nature01315.CrossRefPubMed Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP: Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature. 2003, 421: 388-392. 10.1038/nature01315.CrossRefPubMed
29.
Zurück zum Zitat Holler E, Roncarolo MG, Hintermeier-Knabe R, Eissner G, Ertl B, Schulz U, Knabe H, Kolb HJ, Andreesen R, Wilmanns W: Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant. 2000, 25: 237-241. 10.1038/sj.bmt.1702126.CrossRefPubMed Holler E, Roncarolo MG, Hintermeier-Knabe R, Eissner G, Ertl B, Schulz U, Knabe H, Kolb HJ, Andreesen R, Wilmanns W: Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant. 2000, 25: 237-241. 10.1038/sj.bmt.1702126.CrossRefPubMed
30.
Zurück zum Zitat VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, Chin T, Kusaka S, Geissler F, Pelletier RP, Orosz CG: Human allograft acceptance is associated with immune regulation. J Clin Invest. 2000, 106: 145-155.PubMedCentralCrossRefPubMed VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, Chin T, Kusaka S, Geissler F, Pelletier RP, Orosz CG: Human allograft acceptance is associated with immune regulation. J Clin Invest. 2000, 106: 145-155.PubMedCentralCrossRefPubMed
31.
Zurück zum Zitat Bacchetta R, Bigler M, Touraine JL, Parkman R, Tovo PA, Abrams J, de Waal MR, de Vries JE, Roncarolo MG: High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med. 1994, 179: 493-502. 10.1084/jem.179.2.493.CrossRefPubMed Bacchetta R, Bigler M, Touraine JL, Parkman R, Tovo PA, Abrams J, de Waal MR, de Vries JE, Roncarolo MG: High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med. 1994, 179: 493-502. 10.1084/jem.179.2.493.CrossRefPubMed
32.
Zurück zum Zitat Akbari O, DeKruyff RH, Umetsu DT: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol. 2001, 2: 725-731. 10.1038/90667.CrossRefPubMed Akbari O, DeKruyff RH, Umetsu DT: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol. 2001, 2: 725-731. 10.1038/90667.CrossRefPubMed
33.
Zurück zum Zitat Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM, Bowen G, Rook G, Walker C: Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med. 2002, 8: 625-629. 10.1038/nm0602-625.CrossRefPubMed Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM, Bowen G, Rook G, Walker C: Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med. 2002, 8: 625-629. 10.1038/nm0602-625.CrossRefPubMed
34.
Zurück zum Zitat Chen C, Lee WH, Yun P, Snow P, Liu CP: Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes. J Immunol. 2003, 171: 733-744.CrossRefPubMed Chen C, Lee WH, Yun P, Snow P, Liu CP: Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes. J Immunol. 2003, 171: 733-744.CrossRefPubMed
35.
Zurück zum Zitat Wildbaum G, Netzer N, Karin N: Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. J Clin Invest. 2002, 110: 701-710. 10.1172/JCI200215176.PubMedCentralCrossRefPubMed Wildbaum G, Netzer N, Karin N: Tr1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. J Clin Invest. 2002, 110: 701-710. 10.1172/JCI200215176.PubMedCentralCrossRefPubMed
36.
Zurück zum Zitat McGuirk P, Mills KH: Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol. 2002, 23: 450-455. 10.1016/S1471-4906(02)02288-3.CrossRefPubMed McGuirk P, Mills KH: Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol. 2002, 23: 450-455. 10.1016/S1471-4906(02)02288-3.CrossRefPubMed
37.
Zurück zum Zitat Kullberg MC, Jankovic D, Gorelick PL, Caspar P, Letterio JJ, Cheever AW, Sher A: Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med. 2002, 196: 505-515. 10.1084/jem.20020556.PubMedCentralCrossRefPubMed Kullberg MC, Jankovic D, Gorelick PL, Caspar P, Letterio JJ, Cheever AW, Sher A: Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med. 2002, 196: 505-515. 10.1084/jem.20020556.PubMedCentralCrossRefPubMed
38.
Zurück zum Zitat Morelli AE, Thomson AW: Dendritic cells: regulators of allo-immunity and opportunities for tolerance induction. Immunol Rev. 2003, 196: 125-146. 10.1046/j.1600-065X.2003.00079.x.CrossRefPubMed Morelli AE, Thomson AW: Dendritic cells: regulators of allo-immunity and opportunities for tolerance induction. Immunol Rev. 2003, 196: 125-146. 10.1046/j.1600-065X.2003.00079.x.CrossRefPubMed
39.
Zurück zum Zitat Lu L, Bonham CA, Liang X, Chen Z, Li W, Wang L, Watkins SC, Nalesnik MA, Schlissel MS, Demestris AJ, Fung JJ, Qian S: Liver-derived DEC205+B220+. J Immunol. 2001, 166: 7042-7052.CrossRefPubMed Lu L, Bonham CA, Liang X, Chen Z, Li W, Wang L, Watkins SC, Nalesnik MA, Schlissel MS, Demestris AJ, Fung JJ, Qian S: Liver-derived DEC205+B220+. J Immunol. 2001, 166: 7042-7052.CrossRefPubMed
40.
Zurück zum Zitat Huang FP, Platt N, Wykes M, Major JR, Powell TJ, Jenkins CD, MacPherson GG: A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med. 2000, 191: 435-444. 10.1084/jem.191.3.435.PubMedCentralCrossRefPubMed Huang FP, Platt N, Wykes M, Major JR, Powell TJ, Jenkins CD, MacPherson GG: A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med. 2000, 191: 435-444. 10.1084/jem.191.3.435.PubMedCentralCrossRefPubMed
41.
Zurück zum Zitat Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H: Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity. 2003, 18: 605-617. 10.1016/S1074-7613(03)00113-4.CrossRefPubMed Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H: Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity. 2003, 18: 605-617. 10.1016/S1074-7613(03)00113-4.CrossRefPubMed
42.
Zurück zum Zitat Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T: Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001, 182: 18-32. 10.1034/j.1600-065X.2001.1820102.x.CrossRefPubMed Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T: Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001, 182: 18-32. 10.1034/j.1600-065X.2001.1820102.x.CrossRefPubMed
43.
Zurück zum Zitat Sakaguchi S, Sakaguchi N: Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of auto-immune disease. J Exp Med. 1990, 172: 537-545. 10.1084/jem.172.2.537.CrossRefPubMed Sakaguchi S, Sakaguchi N: Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of auto-immune disease. J Exp Med. 1990, 172: 537-545. 10.1084/jem.172.2.537.CrossRefPubMed
44.
Zurück zum Zitat Mottet C, Uhlig HH, Powrie F: Cutting edge: cure of colitis by CD4(+)CD25(+) regulatory T cells. J Immunol. 2003, 170: 3939-3943.CrossRefPubMed Mottet C, Uhlig HH, Powrie F: Cutting edge: cure of colitis by CD4(+)CD25(+) regulatory T cells. J Immunol. 2003, 170: 3939-3943.CrossRefPubMed
45.
Zurück zum Zitat Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995, 155: 1151-1164.PubMed Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995, 155: 1151-1164.PubMed
46.
Zurück zum Zitat Kohm AP, Carpentier PA, Anger HA, Miller SD: Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol. 2002, 169: 4712-4716.CrossRefPubMed Kohm AP, Carpentier PA, Anger HA, Miller SD: Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol. 2002, 169: 4712-4716.CrossRefPubMed
47.
Zurück zum Zitat Seddon B, Mason D: Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med. 1999, 189: 877-882. 10.1084/jem.189.5.877.PubMedCentralCrossRefPubMed Seddon B, Mason D: Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med. 1999, 189: 877-882. 10.1084/jem.189.5.877.PubMedCentralCrossRefPubMed
48.
Zurück zum Zitat Green EA, Choi Y, Flavell RA: Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity. 2002, 16: 183-191. 10.1016/S1074-7613(02)00279-0.CrossRefPubMed Green EA, Choi Y, Flavell RA: Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity. 2002, 16: 183-191. 10.1016/S1074-7613(02)00279-0.CrossRefPubMed
49.
Zurück zum Zitat Kipnis J, Mizrahi T, Hauben E, Shaked I, Shevach E, Schwartz M: Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci USA. 2002, 99: 15620-15625. 10.1073/pnas.232565399.PubMedCentralCrossRefPubMed Kipnis J, Mizrahi T, Hauben E, Shaked I, Shevach E, Schwartz M: Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci USA. 2002, 99: 15620-15625. 10.1073/pnas.232565399.PubMedCentralCrossRefPubMed
50.
Zurück zum Zitat Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman MA, Naji A, Caton AJ: Thymic selection of CD4+CD25+regulatory T cells induced by an agonist self-peptide. Nat Immunol. 2001, 2: 301-306. 10.1038/86302.CrossRefPubMed Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman MA, Naji A, Caton AJ: Thymic selection of CD4+CD25+regulatory T cells induced by an agonist self-peptide. Nat Immunol. 2001, 2: 301-306. 10.1038/86302.CrossRefPubMed
51.
Zurück zum Zitat Lyon MF, Peters J, Glenister PH, Ball S, Wright E: The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome. Proc Natl Acad Sci USA. 1990, 87: 2433-2437.PubMedCentralCrossRefPubMed Lyon MF, Peters J, Glenister PH, Ball S, Wright E: The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome. Proc Natl Acad Sci USA. 1990, 87: 2433-2437.PubMedCentralCrossRefPubMed
52.
Zurück zum Zitat Godfrey VL, Rouse BT, Wilkinson JE: Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse. Am J Pathol. 1994, 145: 281-286.PubMedCentralPubMed Godfrey VL, Rouse BT, Wilkinson JE: Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse. Am J Pathol. 1994, 145: 281-286.PubMedCentralPubMed
53.
Zurück zum Zitat Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF: Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem. 2001, 276: 37672-37679. 10.1074/jbc.M104521200.CrossRefPubMed Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF: Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem. 2001, 276: 37672-37679. 10.1074/jbc.M104521200.CrossRefPubMed
54.
Zurück zum Zitat Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA: CD4+CD25 high regulatory cells in human peripheral blood. J Immunol. 2001, 167: 1245-1253.CrossRefPubMed Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA: CD4+CD25 high regulatory cells in human peripheral blood. J Immunol. 2001, 167: 1245-1253.CrossRefPubMed
55.
Zurück zum Zitat Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN: Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol. 2001, 31: 1122-1131. 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P.CrossRefPubMed Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN: Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol. 2001, 31: 1122-1131. 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P.CrossRefPubMed
56.
Zurück zum Zitat Taams LS, Vukmanovic-Stejic M, Smith J, Dunne PJ, Fletcher JM, Plunkett FJ, Ebeling SB, Lombardi G, Rustin MH, Bijlsma JW, Lafeber FP, Salmon M, Akbar AN: Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol. 2002, 32: 1621-1630. 10.1002/1521-4141(200206)32:6<1621::AID-IMMU1621>3.0.CO;2-Q.CrossRefPubMed Taams LS, Vukmanovic-Stejic M, Smith J, Dunne PJ, Fletcher JM, Plunkett FJ, Ebeling SB, Lombardi G, Rustin MH, Bijlsma JW, Lafeber FP, Salmon M, Akbar AN: Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol. 2002, 32: 1621-1630. 10.1002/1521-4141(200206)32:6<1621::AID-IMMU1621>3.0.CO;2-Q.CrossRefPubMed
57.
Zurück zum Zitat Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, Isaacs JD, Lechler RI: Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood. 2001, 98: 2736-2744. 10.1182/blood.V98.9.2736.CrossRefPubMed Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, Isaacs JD, Lechler RI: Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood. 2001, 98: 2736-2744. 10.1182/blood.V98.9.2736.CrossRefPubMed
58.
Zurück zum Zitat Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH, Ziegler SF: Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+. J Clin Invest. 2003, 112: 1437-1443. 10.1172/JCI200319441.CrossRefPubMed Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH, Ziegler SF: Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+. J Clin Invest. 2003, 112: 1437-1443. 10.1172/JCI200319441.CrossRefPubMed
59.
Zurück zum Zitat Wildin RS, Smyk-Pearson S, Filipovich AH: Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2002, 39: 537-545. 10.1136/jmg.39.8.537.PubMedCentralCrossRefPubMed Wildin RS, Smyk-Pearson S, Filipovich AH: Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2002, 39: 537-545. 10.1136/jmg.39.8.537.PubMedCentralCrossRefPubMed
60.
Zurück zum Zitat Stephens LA, Mottet C, Mason D, Powrie F: Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol. 2001, 31: 1247-1254. 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M.CrossRefPubMed Stephens LA, Mottet C, Mason D, Powrie F: Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol. 2001, 31: 1247-1254. 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M.CrossRefPubMed
61.
Zurück zum Zitat Wing K, Ekmark A, Karlsson H, Rudin A, Suri-Payer E: Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology. 2002, 106: 190-199. 10.1046/j.1365-2567.2002.01412.x.PubMedCentralCrossRefPubMed Wing K, Ekmark A, Karlsson H, Rudin A, Suri-Payer E: Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology. 2002, 106: 190-199. 10.1046/j.1365-2567.2002.01412.x.PubMedCentralCrossRefPubMed
62.
Zurück zum Zitat Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH: Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med. 2001, 193: 1285-1294. 10.1084/jem.193.11.1285.PubMedCentralCrossRefPubMed Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH: Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med. 2001, 193: 1285-1294. 10.1084/jem.193.11.1285.PubMedCentralCrossRefPubMed
63.
Zurück zum Zitat Suto A, Nakajima H, Ikeda K, Kubo S, Nakayama T, Taniguchi M, Saito Y, Iwamoto I: CD4(+)CD25(+) T-cell development is regulated by at least 2 distinct mechanisms. Blood. 2002, 99: 555-560. 10.1182/blood.V99.2.555.CrossRefPubMed Suto A, Nakajima H, Ikeda K, Kubo S, Nakayama T, Taniguchi M, Saito Y, Iwamoto I: CD4(+)CD25(+) T-cell development is regulated by at least 2 distinct mechanisms. Blood. 2002, 99: 555-560. 10.1182/blood.V99.2.555.CrossRefPubMed
64.
Zurück zum Zitat Thorstenson KM, Khoruts A: Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol. 2001, 167: 188-195.CrossRefPubMed Thorstenson KM, Khoruts A: Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol. 2001, 167: 188-195.CrossRefPubMed
65.
Zurück zum Zitat Apostolou I, Von Boehmer H: In vivo instruction of suppressor commitment in naive T cells. J Exp Med. 2004, 199: 1401-1408. 10.1084/jem.20040249.PubMedCentralCrossRefPubMed Apostolou I, Von Boehmer H: In vivo instruction of suppressor commitment in naive T cells. J Exp Med. 2004, 199: 1401-1408. 10.1084/jem.20040249.PubMedCentralCrossRefPubMed
66.
Zurück zum Zitat Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, Shevach EM: CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med. 2002, 196: 237-246. 10.1084/jem.20020590.PubMedCentralCrossRefPubMed Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, Shevach EM: CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med. 2002, 196: 237-246. 10.1084/jem.20020590.PubMedCentralCrossRefPubMed
67.
Zurück zum Zitat Grundstrom S, Cederbom L, Sundstedt A, Scheipers P, Ivars F: Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4(+)CD25(+) regulatory T cells in vivo. J Immunol. 2003, 170: 5008-5017.CrossRefPubMed Grundstrom S, Cederbom L, Sundstedt A, Scheipers P, Ivars F: Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4(+)CD25(+) regulatory T cells in vivo. J Immunol. 2003, 170: 5008-5017.CrossRefPubMed
68.
Zurück zum Zitat Duthoit CT, Nguyen P, Geiger TL: Antigen nonspecific suppression of T cell responses by activated stimulation-refractory CD4(+) T cells. J Immunol. 2004, 172: 2238-2246.CrossRefPubMed Duthoit CT, Nguyen P, Geiger TL: Antigen nonspecific suppression of T cell responses by activated stimulation-refractory CD4(+) T cells. J Immunol. 2004, 172: 2238-2246.CrossRefPubMed
69.
Zurück zum Zitat Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA: Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors. J Immunol. 2002, 169: 4183-4189.CrossRefPubMed Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA: Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors. J Immunol. 2002, 169: 4183-4189.CrossRefPubMed
70.
Zurück zum Zitat Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM: Conversion of peripheral CD4+. J Exp Med. 2003, 198: 1875-1886. 10.1084/jem.20030152.PubMedCentralCrossRefPubMed Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM: Conversion of peripheral CD4+. J Exp Med. 2003, 198: 1875-1886. 10.1084/jem.20030152.PubMedCentralCrossRefPubMed
71.
Zurück zum Zitat Verhasselt V, Vosters O, Beuneu C, Nicaise C, Stordeur P, Goldman M: Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells. Eur J Immunol. 2004, 34: 762-772. 10.1002/eji.200324552.CrossRefPubMed Verhasselt V, Vosters O, Beuneu C, Nicaise C, Stordeur P, Goldman M: Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells. Eur J Immunol. 2004, 34: 762-772. 10.1002/eji.200324552.CrossRefPubMed
72.
Zurück zum Zitat Masuyama J, Kaga S, Kano S, Minota S: A novel costimulation pathway via the 4C8 antigen for the induction of CD4+regulatory T cells. J Immunol. 2002, 169: 3710-3716.CrossRefPubMed Masuyama J, Kaga S, Kano S, Minota S: A novel costimulation pathway via the 4C8 antigen for the induction of CD4+regulatory T cells. J Immunol. 2002, 169: 3710-3716.CrossRefPubMed
73.
Zurück zum Zitat Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL: CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 2002, 420: 502-507. 10.1038/nature01152.CrossRefPubMed Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL: CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 2002, 420: 502-507. 10.1038/nature01152.CrossRefPubMed
74.
Zurück zum Zitat Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH: Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med. 2002, 196: 255-260. 10.1084/jem.20020394.PubMedCentralCrossRefPubMed Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH: Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med. 2002, 196: 255-260. 10.1084/jem.20020394.PubMedCentralCrossRefPubMed
75.
Zurück zum Zitat Kriegel MA, Lohmann T, Gabler C, Blank N, Kalden JR, Lorenz HM: Defective suppressor function of human CD4+ CD25+regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med. 2004, 199: 1285-1291. 10.1084/jem.20032158.PubMedCentralCrossRefPubMed Kriegel MA, Lohmann T, Gabler C, Blank N, Kalden JR, Lorenz HM: Defective suppressor function of human CD4+ CD25+regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med. 2004, 199: 1285-1291. 10.1084/jem.20032158.PubMedCentralCrossRefPubMed
Metadaten
Titel
Regulating the immune system: the induction of regulatory T cells in the periphery
verfasst von
Jane H Buckner
Steven F Ziegler
Publikationsdatum
01.09.2004
Verlag
BioMed Central
Erschienen in
Arthritis Research & Therapy / Ausgabe 5/2004
Elektronische ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar1226

Weitere Artikel der Ausgabe 5/2004

Arthritis Research & Therapy 5/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.